title: Development of the OnTrack Diabetes Program.
abstract: BACKGROUND
  Type 2 diabetes affects an estimated 347 million people worldwide and often leads to serious complications including blindness, kidney disease, and limb amputation. Comorbid dysphoria is common and is an independent risk factor for poor glycaemic control. Professional support for diabetes self-management and dysphoria has limited availability and involves high costs, especially after regular hours, and in rural and remote areas. Web-based cognitive behavior therapy offers highly accessible, acceptable, and cost-effective support for people with diabetes. This paper describes the development of OnTrack Diabetes, a self-guided, Web-based program to promote improved physical and emotional self-management in people with Type 2 diabetes.
  
  
  OBJECTIVE
  The objective of the study is to describe the development of the OnTrack Diabetes program, which is a self-guided, Web-based program aimed to promote euthymia and improved disease self-management in people with Type 2 diabetes.
  
  
  METHODS
  Semistructured interviews with 12 general practitioners and 13 patients with Type 2 diabetes identified enablers of and barriers to effective diabetes self-management, requirements for additional support, and potential program elements. Existing resources and research data informed the development of content, and consultants from relevant disciplines provided feedback on draft segments and reviewed the program before release. Using a self-guided delivery format contained costs, in addition to adapting program features and modules from an existing OnTrack program.
  
  
  RESULTS
  A separate paper describes the protocol for a randomized controlled trial to provide this required evaluation.
  
  
  CONCLUSIONS
  Development of the OnTrack Diabetes program demonstrates strategies that help ensure that a program is acceptable to users. The next stages involve testing users' experiences and examining the program's effectiveness and cost-effectiveness in randomized controlled trials.
  
  
  BACKGROUND
  The Australian New Zealand Clinical Trials Registry (ACTRN): 12614001126606; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12614001126606 (Archived by WebCite at http://www.webcitation.org/6U0Fh3vOj).
authors.affiliation: Queensland University of Technology, Institute of Health and Biomedical Innovation, Brisbane, Australia. mandy.cassimatis@usq.edu.au.
authors.forename: Mandy
authors.identifier: http://orcid.org/0000-0002-3678-4535
authors.initials: M
authors.lastname: Cassimatis
authors.forename: David J
authors.identifier: http://orcid.org/0000-0001-9072-8828
authors.initials: DJ
authors.lastname: Kavanagh
authors.forename: Andrew P
authors.identifier: http://orcid.org/0000-0002-6849-6116
authors.initials: AP
authors.lastname: Hills
authors.forename: Anthony C
authors.identifier: http://orcid.org/0000-0002-7756-5136
authors.initials: AC
authors.lastname: Smith
authors.forename: Paul A
authors.identifier: http://orcid.org/0000-0001-5931-642X
authors.initials: PA
authors.lastname: Scuffham
authors.forename: Steven
authors.identifier: http://orcid.org/0000-0002-9414-3621
authors.initials: S
authors.lastname: Edge
authors.forename: Jeremy
authors.identifier: http://orcid.org/0000-0002-2249-1045
authors.initials: J
authors.lastname: Gibson
authors.forename: Christian
authors.initials: C
authors.lastname: Gericke
keywords: Internet; anxiety; depression; intervention; online; protocol; randomized; self-management; type 2 diabetes